Showing 11,841 - 11,860 results of 34,801 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 5 ((point decrease) OR (nn decrease)) ))', query time: 0.88s Refine Results
  1. 11841
  2. 11842

    Factors associated with postoperative signs and symptoms in teeth with periapical lesion: a longitudinal study by Erlange Andrade Borges Silva (14224193)

    Published 2022
    “…Female gender (beta = 1.02; p < 0.01), mandibular teeth (beta = 25.50; p < 0.01), medium root canal amplitude (beta = 0.93; p = 0.03), and edema (beta = 1.88; p < 0.01) were associated with increased postoperative pain and tenderness, while the use of analgesics (beta = -1.82; p < 0.01) and time in days (beta = -0.23; p < 0.01) were associated with a decrease in these signs and symptoms. …”
  3. 11843

    Crystal structure and cytotoxic activities of a bis(pyrrolyl-imine) gold(III) complex by Daniel De Moraes Profirio (2885411)

    Published 2016
    “…Cytotoxic activity of [Au(pyren)]<sup>+</sup> was active against three tumorigenic cell lines with IC<sub>50</sub> values of 35 μM. Interaction studies with CT-DNA by fluorescence and competition with ethidium bromide (EB) showed a quenching of the emission band of DNA with a Stern–Volmer quenching constant value of (3.0 ± 0.1) × 10<sup>4</sup> M<sup>−1</sup> and a decrease in fluorescence quenching of EB-DNA system, respectively, confirming that DNA is a possible target for the complex via an intercalative binding, which was confirmed by DNA conformational changes observed with circular dichroism spectroscopy.…”
  4. 11844
  5. 11845

    4T1-luc2-1A4 tumor metastases in syngeneic Balb/c mice. by Jae-Beom Kim (25395)

    Published 2010
    “…<p>(A) Metastases of 4T1-luc2-1A4 tumors in Balb/c mice. 5.0×10<sup>4</sup> cells were orthotopically implanted into mammary fat pads of the mice (n = 16)<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0009364#pone.0009364-Jenkins1" target="_blank">[1]</a>. …”
  6. 11846

    Development of a Mechanistic and Data-Driven Model for Multiphase Flow Leak Detection in Pipeline by Barooah, Abinash

    Published 2024
    “…The effect of different pressure constraints, pipe length, pipe diameter, two-phase fluid rheology, leak diameter, leak location, outlet liquid volume fraction, and flowing liquid hold-up on leak size, pressure, and flow rate is analyzed. Decreasing the liquid fraction in the outlet section of the leak leads to a slight increase (6% average) in the inlet mass flow rate and a significant decrease (50% average) in the outlet mass flow rate for fixed pressure constraints, resulting in an increased leak flow rate, pressure, and density. …”
    Get full text
    Get full text
  7. 11847

    Consequence of the normalization of <i>Dyrk1a</i> in glutamatergic neurons of Dp1Yey mice on animal cognition. by Véronique Brault (160595)

    Published 2021
    “…Data are presented as point plots with mean ± SD. (n = 8–15 per genotype, *p<0.05, **p<0.01). …”
  8. 11848

    Potency of CCh (pD<sub>2</sub>) and Atropine (pA<sub>2</sub>) on the ileum (a, b, c) and on the colon (d, e, f) from mice with chronic colitis. by Rita Aldini (92787)

    Published 2012
    “…After induction of chronic colitis, Charbacol pEC<sub>50</sub> decreased by 8.71 times in the ileum and 2.34 times in the colon and Atropine p<i>A</i><sub>2</sub> was increased by 1.35 and 3.09 times in the ileum and the colon respectively, compared with the corresponding intestinal segments of control mice. …”
  9. 11849
  10. 11850

    Enhancement of biological effectiveness of carbon-ion beams by applying a longitudinal magnetic field by Taku Inaniwa (6239012)

    Published 2019
    “…</p> <p><b>Methods and materials:</b> Human cancer and normal cell lines were exposed to low (12 keV/<i>μ</i>m) and high (50 keV/<i>μ</i>m) linear energy transfer (LET) carbon-ion beams under the longitudinal magnetic fields of <i>B</i><sub>//</sub> = 0, 0.1, 0.2, 0.3, or 0.6 T generated by a solenoid magnet. …”
  11. 11851

    Gingival recession treatment with concentrated growth factor membrane: a comparative clinical trial by Serap Karakış AKCAN (8650455)

    Published 2020
    “…A statistically significant decrease was observed in CAL, RD, and RW, and KTT increased in all groups at three and six months compared with the baseline. …”
  12. 11852

    ETCO<sub>2</sub> in an animal undergoing two-lung, left-lung, and right-lung ventilations via a standard endotracheal tube during cardiopulmonary resuscitation. by Dong Hyun Ryu (5095394)

    Published 2018
    “…Immediately after the endotracheal tube was advanced into the right main bronchus (point E), ETCO<sub>2</sub> decreased to 12.5 mmHg and remained between 10.0 and 11.0 mmHg after stabilization.…”
  13. 11853

    DataSheet1_A lightweight MHDI-DETR model for detecting grape leaf diseases.pdf by Zilong Fu (20392494)

    Published 2024
    “…The findings from the experiments suggest that The MHDI-DETR model results in a 56% decrease in parameters and a 49% reduction in floating-point operations, respectively, compared with the RT-DETR model, in terms of accuracy, the model achieved precision rates of 96.9%, 92.6%, and 72.5% for accuracy, mAP50, and mAP50:95, respectively. …”
  14. 11854

    Data Sheet 1_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

    Published 2025
    “…Evidence supports the use of TXL plus WM for reducing angina frequency [SMD −2.50, 95% CI (−3.53, −1.48)], improving seattle angina questionnaire scores (P < 0.05), decreasing nitroglycerin dose [SMD −1.63, 95% CI (−2.26, −1.00)], and shortening angina duration [MD −1.50 min/once, 95% CI (−1.98, −1.02)]. …”
  15. 11855

    Data Sheet 2_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

    Published 2025
    “…Evidence supports the use of TXL plus WM for reducing angina frequency [SMD −2.50, 95% CI (−3.53, −1.48)], improving seattle angina questionnaire scores (P < 0.05), decreasing nitroglycerin dose [SMD −1.63, 95% CI (−2.26, −1.00)], and shortening angina duration [MD −1.50 min/once, 95% CI (−1.98, −1.02)]. …”
  16. 11856

    Data Sheet 3_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

    Published 2025
    “…Evidence supports the use of TXL plus WM for reducing angina frequency [SMD −2.50, 95% CI (−3.53, −1.48)], improving seattle angina questionnaire scores (P < 0.05), decreasing nitroglycerin dose [SMD −1.63, 95% CI (−2.26, −1.00)], and shortening angina duration [MD −1.50 min/once, 95% CI (−1.98, −1.02)]. …”
  17. 11857

    Data Sheet 4_Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized cont... by Shi-Bing Liang (10200806)

    Published 2025
    “…Evidence supports the use of TXL plus WM for reducing angina frequency [SMD −2.50, 95% CI (−3.53, −1.48)], improving seattle angina questionnaire scores (P < 0.05), decreasing nitroglycerin dose [SMD −1.63, 95% CI (−2.26, −1.00)], and shortening angina duration [MD −1.50 min/once, 95% CI (−1.98, −1.02)]. …”
  18. 11858
  19. 11859
  20. 11860

    BC CLC-Pred: a freely available web-application for quantitative and qualitative predictions of substance cytotoxicity in relation to human breast cancer cell lines by A.A. Lagunin (810465)

    Published 2023
    “…The mean accuracies of prediction <i>r</i><sup>2</sup>, RMSE, Balance Accuracy for the selected (Q)SAR models calculated by 5F CV were 0.599, 0.679 and 0.875, respectively. As a result, BC CLC-Pred provides simultaneous quantitative and qualitative predictions of IC<sub>50</sub> and IG<sub>50</sub> values for most of the nine breast cancer cell lines, which may be helpful in selecting promising compounds and optimizing lead compounds during the development of new antineoplastic agents against breast cancer.…”